Cardiology
News
Mislabeled clopidogrel lot recalled, may contain simvastatin
Conference Coverage
PCSK9 inhibitors unexpectedly link with lower VTE, aortic stenosis
From the Journals
Interim guidance for CPR in patients with COVID-19
Performing CPR on patients with COVID-19 raises unique challenges. Interim guidance suggests approaches to mitigate risk to patients and providers...
From the Journals
COVID-19: How intensive care cardiology can inform the response
Conference Coverage
HFpEF: Gender difference in sacubitril/valsartan response remains mystery
Why did women on sacubitril/valsartan get a 27% reduction in cardiovascular death and heart failure hospitalization, while the men got nothing?
Feature
Protean manifestations of COVID-19: “Our ignorance is profound”
“Make sure they didn’t die in vain.”
From the Journals
Evidence suggests possible RAS-blocker benefit in COVID-19 patients
...
Latest News
No hydroxychloroquine benefit in small, randomized COVID-19 trial
Two experts caution that because of confounding, the trial is unable to answer convincingly the question of whether HCQ can benefit COVID-19...
Myth of the Month
COVID-19 mythconceptions
We are in a position where we need to take in what we can and assess the best data available.
Feature
COVID-19 cases highlight longstanding racial disparities in health care
Data on higher infection and death rates in African Americans from COVID-19 may serve as a call to action.
From the Journals
Troponins touted as ‘ally’ in COVID-19 triage, but message is nuanced
A consequence of not measuring hs-cTn may be to “ignore the plethora of ischemic and nonischemic causes of myocardial injury related to COVID-19...